NCT01736683 2022-10-24Study of Sotatercept for the Treatment of Anemia in low-or Intermediate-1 Risk Myelodysplastic Syndromes (MDS) or Non-proliferative Chronic Myelomonocytic Leukemia (CMML)Merck Sharp & Dohme LLCPhase 2 Completed74 enrolled 33 charts